XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Capital stock
Capital in excess of par value
Retained earnings
Retained earnings
Revision of Prior Period, Accounting Standards Update, Adjustment
Accumulated foreign currency adjustment attributable to parent
Accumulated defined benefit plans adjustment attributable to parent
Accumulated other comprehensive (loss) income
Treasury stock
Balance at the beginning of the year at Dec. 31, 2019   $ 2,662 $ 832,821 $ 6,387,612 $ (360) $ (286,248) $ (246,891)   $ (1,574,464)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued   6              
Issuance of common stock under employee stock plans     8,897           9,052
Share-based compensation expense     19,053            
Net income $ 446,833     446,833          
Cash dividends paid       (82,399)          
Translation adjustments           (49,025)      
Change in long-term intercompany notes           (1,024)      
Net investment hedge instruments (loss) gain, net of tax of $1,459 and $2,339 for the quarter ended June 30, 2021 and 2020, and $(4,479) and $(6,778) for the six months ended June 30, 2021 and 2020, respectively           21,045      
Amortization of net actuarial loss and other, net of tax of $(527) and $(531) for the quarter ended June 30, 2021 and 2020, and $(1,054) and $(1,062) for the six months ended June 30, 2021 and 2020, respectively             3,366    
Purchase of treasury stock                 (4,496)
Balance at the end of the year at Jun. 30, 2020 5,486,440 2,668 860,771 6,751,686   (315,252) (243,525) $ (558,777) (1,569,908)
Balance at the beginning of the year at Mar. 31, 2020   2,664 837,755 6,626,703   (330,530) (245,208)   (1,565,381)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued   4              
Issuance of common stock under employee stock plans     11,811           (132)
Share-based compensation expense     11,205            
Net income 166,217     166,217          
Cash dividends paid       (41,234)          
Translation adjustments           18,064      
Change in long-term intercompany notes           4,477      
Net investment hedge instruments (loss) gain, net of tax of $1,459 and $2,339 for the quarter ended June 30, 2021 and 2020, and $(4,479) and $(6,778) for the six months ended June 30, 2021 and 2020, respectively           (7,263)      
Amortization of net actuarial loss and other, net of tax of $(527) and $(531) for the quarter ended June 30, 2021 and 2020, and $(1,054) and $(1,062) for the six months ended June 30, 2021 and 2020, respectively             1,683    
Purchase of treasury stock                 (4,395)
Balance at the end of the year at Jun. 30, 2020 5,486,440 2,668 860,771 6,751,686   (315,252) (243,525) (558,777) (1,569,908)
Balance at the beginning of the year at Dec. 31, 2020 5,949,346 2,676 921,752 7,094,656   (250,748) (253,720)   (1,565,270)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued   8              
Issuance of common stock under employee stock plans     19,446           7,452
Share-based compensation expense     23,593            
Net income 450,912     450,912          
Cash dividends paid       (92,167)          
Translation adjustments           (13,953)      
Change in long-term intercompany notes           (5,566)      
Net investment hedge instruments (loss) gain, net of tax of $1,459 and $2,339 for the quarter ended June 30, 2021 and 2020, and $(4,479) and $(6,778) for the six months ended June 30, 2021 and 2020, respectively           13,846      
Amortization of net actuarial loss and other, net of tax of $(527) and $(531) for the quarter ended June 30, 2021 and 2020, and $(1,054) and $(1,062) for the six months ended June 30, 2021 and 2020, respectively             3,260    
Purchase of treasury stock                 (12,878)
Balance at the end of the year at Jun. 30, 2021 6,343,299 2,684 964,791 7,453,401   (256,421) (250,460) (506,881) (1,570,696)
Balance at the beginning of the year at Mar. 31, 2021   2,678 928,412 7,267,856   (260,785) (252,090)   (1,565,323)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued   6              
Issuance of common stock under employee stock plans     24,226           (492)
Share-based compensation expense     12,153            
Net income 231,679     231,679          
Cash dividends paid       (46,134)          
Translation adjustments           7,547      
Change in long-term intercompany notes           1,329      
Net investment hedge instruments (loss) gain, net of tax of $1,459 and $2,339 for the quarter ended June 30, 2021 and 2020, and $(4,479) and $(6,778) for the six months ended June 30, 2021 and 2020, respectively           (4,512)      
Amortization of net actuarial loss and other, net of tax of $(527) and $(531) for the quarter ended June 30, 2021 and 2020, and $(1,054) and $(1,062) for the six months ended June 30, 2021 and 2020, respectively             1,630    
Purchase of treasury stock                 (4,881)
Balance at the end of the year at Jun. 30, 2021 $ 6,343,299 $ 2,684 $ 964,791 $ 7,453,401   $ (256,421) $ (250,460) $ (506,881) $ (1,570,696)